BCOP Self-Study
These modules focus on literature published within the last two years. Participants will learn about new developments and cutting-edge findings through case-based discussions that help you apply the information presented.
Self Study 2024 Release I is now available - it contains 9 ACPE and BCOP CEs total.
Individual Learning Opportunities
Clear filter
-
Individual
Self Study 2024 Release I: Navigating Oncology Drug Shortages
On-demand This module will review literature exploring strategies to overcome recent drug shortages while also ensuring equity remains uncompromised for underserved patient populations in this public health crisis. Learn more -
Individual
Self Study 2024 Release I: Ocular Toxicities with Antineoplastics
On-demand In this module, participants will explore various ocular adverse events associated with different classes of antineoplastics. Learn more -
Individual
Self-Study 2024 Release I: PARP Inhibitor Combination Regimens for mCRPC
On-demand Develop appropriate treatment and supportive care plans utilizing PARP inhibitor combination therapy for patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC). Learn more -
Individual
Self-Study 2024 Release I: Updates in Uveal Melanoma
On-demand The purpose of this course is to review treatment options and updates in the management of uveal melanoma. Learn more -
Individual
Self Study 2023 Release II: Clinical Controversies with Immune Checkpoint Inhibitor Therapies
On-demand In this module, participants will explore existing clinical controversies associated with immune checkpoint inhibitor therapy and consider the possible implications these controversies may have on clinical practice. Learn more -
Individual
Self Study 2023 Release II: Updates in the Management of Hemophilia: Gene Therapy for Hemophilia Management
On-demand In this module, participants will explore recent developments in the use of gene therapy for hemophilia management and provide practical steps for implementation of gene therapy at their health care institution. Learn more -
Individual
Self Study 2023 Release II: Changing Landscape of Clinical Oncology Trial Design
On-demand This module discusses the reasons for changes in clinical trial design, the newer trial designs, and issues and priorities in clinical research. Learn more -
Individual
Self Study 2023 Release II: Oral Agents for the Management of Acute Myeloid Leukemia
On-demand This module discusses roles of oral chemotherapy agents and current recommendations on management of toxicities associated with these agents in AML treatment. Learn more